TVRD Tvardi Therapeutics, Inc.
Company Analysis
Latest News
🔴 Tvardi Therapeutics is trading 5.8% down today as specific catalyst remains unclear
Tvardi Therapeutics is trading 5.8% down at $1.63, despite biotechnology and major U.S. indexes moving higher; the specific catalyst remains unclear. - The...
🟢 Tvardi Therapeutics is trading 6.3% up today ahead of its September 14, 2026 presentation
Tvardi Therapeutics is trading at $1.99 (+6.26%) ahead of its September 14, 2026 presentation at the H.C. Wainwright Global Investment Conference. • The...
🟢 Tvardi Therapeutics is trading 5.18% up today as major U.S. indexes rise
Tvardi Therapeutics is trading 5.18% higher at $1.93, moving alongside a broadly stronger U.S. market. - The S&P 500, Nasdaq Composite, and Dow Jones...
🟢 Tvardi Therapeutics is trading 6% up today as biotech ETF XBI gains 2.75%
Tvardi Therapeutics is trading at $1.85, up 6.02%, in a move that appears primarily sector-driven, with biotech ETF XBI up 2.75% during regular trading. - No...
🟢 Tvardi Therapeutics is trading 6.81% up today in pre-market — catalyst remains unclear
Tvardi Therapeutics is trading at $1.86 (+6.81%) in pre-market, but the catalyst is unclear. - No clear company-specific announcement dated September 2, 2026...